Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.
The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers.
Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.
The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care.
Other Pharmaceutical & Medical Technology Assets
-
Alloy Therapeutics
Alloy is a biotechnology company that is developing and commercializing drug discovery platforms and services
Read more -
Ansa Biotechnologies
Ansa is a synthetic biology company whose mission is to develop automated technology to synthesize strands of DNA in a fast, reliable and non-toxic matter.
Read more -
Ciitizen
Ciitizen is a clinical trial patient recruitment platform that takes a patient-centric approach (versus provider/payer/pharma-centric) to establish a high-quality double-sided marketplace for matching patients and trials.
Read more -
Collective Health
Collective Health (“CH”) is an enterprise software company building an end-to-end self-insurance platform to help employers process, manage and analyze health benefits.
Read more -
Datavant
Datavant's mission is to connect the world's health data to improve patient outcomes.
Read more -
Certara
Certara accelerates medicines using its proprietary biosimulation software and technology to transform traditional drug discovery and development.
Read more
